Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
428
-
Total shares
-
81.6M
-
Shares change
-
-4.11M
-
Total reported value, excl. options
-
$7.58B
-
Value change
-
-$375M
-
Put/Call ratio
-
0.72
-
Number of buys
-
213
-
Number of sells
-
-162
-
Price
-
$92.86
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2016
433 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2016.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 428 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.6M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (6.7M shares), BAMCO INC /NY/ (6.58M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.53M shares), Fundsmith LLP (4.47M shares), BlackRock Fund Advisors (3.55M shares), BlackRock Institutional Trust Company, N.A. (3.27M shares), Select Equity Group, L.P. (2.91M shares), STATE STREET CORP (2.77M shares), Neuberger Berman Group LLC (2.66M shares), and ATLANTA CAPITAL MANAGEMENT CO L L C (2.51M shares).
This table shows the top 428 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.